Dr. Marvin Tanenbaum

Biography

Marvin Tanenbaum is a group leader at the Hubrecht Institute and an investigator at the Oncode Institute, serving as a professor in the Department of Bionanoscience at TU Delft. He received his PhD in 2010 with highest honors from Utrecht University, where he worked on cell division under the guidance of Professor René Medema. Following his doctoral studies, he completed a postdoc in the group of Professor Ron Vale at UCSF from 2011 to 2015, which shaped his interest in the mechanisms underlying gene expression control. Tanenbaum has pioneered innovative techniques like the SunTag system and contributed to the development of CRISPR activation methods that enhance the expression of endogenous genes. In 2015, he became a group leader at the Hubrecht Institute, and since then, he has acquired significant funding through prestigious grants such as the ERC Starting Grant (2015), VIDI award (2018), and ERC Consolidator Grant (2022). He was honored as an HHMI International Research Scholar and a junior investigator at the Oncode Institute, aiming to translate findings from basic science into clinical applications for cancer therapy. His research focuses on understanding gene expression regulation at a single-molecule level in various contexts, including human cells and viruses, utilizing advanced fluorescence imaging methods to study dynamics in living cells. Tanenbaum's contributions have been recognized with awards, including being selected as an EMBO Young Investigator.

Research Interests